Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Cell And Gene Therapy In Conversation
Industry experts share strategies to overcome key barriers in CGT development, from reproducibility to scale-up. Gain practical insights to help teams move faster and more reliably toward commercialization.
-
Enabling Quality By Design
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
Navigating The Regulatory Space To Biosimilar Approval
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
Aggregation In Antibody-Drug Conjugates: Causes And Mitigation
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod
To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.
-
Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity
Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.
-
Scalable Production Of High-Purity Nanobodies Using Yeast Expression System
Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.
-
Streptozotocin-Induced Diabetic Peripheral Neuropathic Pain Model
Emerging research highlights that insulin deficiency drives sensory neuropathy, and early insulin therapy may help prevent or alleviate chronic diabetic neuropathic pain.
FORMULATION DEVELOPMENT SOLUTIONS
- PBPK Predictive Modeling Services
- Unlock Amorphous Solubility Enhancement For Challenging Compounds
- Rapid Sterility Testing: Actionable Results In Less Than 5 Hours
- Allegro™ Ready Filter Sets
- Controlled Substances
- Paclitaxel-Induced Peripheral Neuropathic Pain Model
- CDO Services: Agile. Flexible. Focused On You.
- Advancing Vaccines From Preclinical Development To Commercial Supply
- How Product Quality Translates To Better Results
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Assets Of Sutro Biopharma To Be Auctioned – December 2025
- Results Of Nanoform Collaborative Study To Be Presented At U.S. Drug Delivery & Formulation (DDF) Summit
- Ridge Biotechnologies Secures $25M Seed Funding To Pioneer AI-Powered Enzyme & Drug Design
- Proxio Group And Federal Equipment Announce Used Equipment Auction For September 25-30
- Gilead Sciences Begins Construction On New Drug Manufacturing Facility In California
- Herma US To Exhibit Robotic Labeling Cell And Front/Back/Wrap Labeling Systems At Pack Expo 2025
- Amgen To Invest $600+ Million With New Science And Innovation Center In California
- CDMO Grand River Aseptic Manufacturing Announces Denis Johnson As New CEO
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture
- ROSS DPM-150 Double Planetary Mixer Designed For High-Volume Production In Hazardous Locations